La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Zhejiang Xianju PharmaceuticalLtd Crescita futura
Future criteri di controllo 3/6
Zhejiang Xianju PharmaceuticalLtd is forecast to grow earnings and revenue by 20% and 14.7% per annum respectively. EPS is expected to grow by 19.9% per annum. Return on equity is forecast to be 12.3% in 3 years.
Informazioni chiave
20.0%
Tasso di crescita degli utili
19.9%
Tasso di crescita dell'EPS
Pharmaceuticals crescita degli utili | 18.8% |
Tasso di crescita dei ricavi | 14.7% |
Rendimento futuro del capitale proprio | 12.3% |
Copertura analitica | Good |
Ultimo aggiornamento | 01 Aug 2024 |
Aggiornamenti recenti sulla crescita futura
Nessun aggiornamento
Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
12/31/2026 | 6,300 | 1,007 | N/A | 1,019 | 6 |
12/31/2025 | 5,444 | 829 | N/A | 928 | 6 |
12/31/2024 | 4,711 | 679 | N/A | 739 | 6 |
3/31/2024 | 4,204 | 581 | 385 | 635 | N/A |
12/31/2023 | 4,123 | 563 | 361 | 595 | N/A |
9/30/2023 | 4,164 | 692 | 493 | 732 | N/A |
3/31/2023 | 4,288 | 755 | 414 | 673 | N/A |
1/1/2023 | 4,380 | 749 | 327 | 609 | N/A |
9/30/2022 | 4,493 | 689 | 239 | 535 | N/A |
6/30/2022 | 4,442 | 676 | 277 | 552 | N/A |
3/31/2022 | 4,405 | 636 | 318 | 599 | N/A |
1/1/2022 | 4,357 | 619 | 409 | 658 | N/A |
9/30/2021 | 4,402 | 605 | 667 | 807 | N/A |
6/30/2021 | 4,391 | 573 | 644 | 779 | N/A |
3/31/2021 | 4,276 | 548 | 655 | 759 | N/A |
12/31/2020 | 4,019 | 505 | 671 | 789 | N/A |
9/30/2020 | 3,873 | 478 | 452 | 589 | N/A |
6/30/2020 | 3,620 | 442 | 165 | 415 | N/A |
3/31/2020 | 3,618 | 420 | 234 | 512 | N/A |
12/31/2019 | 3,709 | 410 | 257 | 520 | N/A |
9/30/2019 | 3,741 | 381 | 162 | 358 | N/A |
6/30/2019 | 3,723 | 352 | 313 | 455 | N/A |
3/31/2019 | 3,628 | 319 | 275 | 422 | N/A |
12/31/2018 | 3,622 | 301 | 24 | 193 | N/A |
9/30/2018 | 3,514 | 277 | 74 | 316 | N/A |
6/30/2018 | 3,337 | 249 | 27 | 204 | N/A |
3/31/2018 | 3,116 | 231 | -5 | 116 | N/A |
12/31/2017 | 2,853 | 207 | N/A | 179 | N/A |
9/30/2017 | 2,671 | 187 | N/A | 205 | N/A |
6/30/2017 | 2,572 | 168 | N/A | 125 | N/A |
3/31/2017 | 2,547 | 149 | N/A | 133 | N/A |
12/31/2016 | 2,504 | 146 | N/A | 156 | N/A |
9/30/2016 | 2,457 | 135 | N/A | 214 | N/A |
6/30/2016 | 2,504 | 123 | N/A | 243 | N/A |
3/31/2016 | 2,441 | 108 | N/A | 257 | N/A |
12/31/2015 | 2,480 | 107 | N/A | 200 | N/A |
9/30/2015 | 2,466 | 88 | N/A | 257 | N/A |
6/30/2015 | 2,461 | 71 | N/A | 269 | N/A |
3/31/2015 | 2,473 | 60 | N/A | 118 | N/A |
12/31/2014 | 2,471 | 57 | N/A | 142 | N/A |
9/30/2014 | 2,408 | 45 | N/A | 3 | N/A |
6/30/2014 | 2,370 | 38 | N/A | 62 | N/A |
3/31/2014 | 2,373 | 51 | N/A | 59 | N/A |
12/31/2013 | 2,315 | 61 | N/A | 63 | N/A |
9/30/2013 | 2,326 | 78 | N/A | 25 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: 002332's forecast earnings growth (20% per year) is above the savings rate (2.9%).
Guadagni vs Mercato: 002332's earnings (20% per year) are forecast to grow slower than the CN market (21.9% per year).
Guadagni ad alta crescita: 002332's earnings are expected to grow significantly over the next 3 years.
Ricavi vs Mercato: 002332's revenue (14.7% per year) is forecast to grow faster than the CN market (13.4% per year).
Ricavi ad alta crescita: 002332's revenue (14.7% per year) is forecast to grow slower than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: 002332's Return on Equity is forecast to be low in 3 years time (12.3%).